Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
US7795273B2 · kind B2 · utility
45Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2006 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | May 13, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel pyrazolo[1,5-a]pyridine-3-carboxylic acid compounds of the formulain which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.